Monday, March 30, 2009
Taking in beautiful vistas, stargazing, hiking and biking are all activities Silicon Valley residents may soon be able to enjoy thanks to mounting political pressure to clean up a former Air Force radar station atop Mt. Umunhum.The former Almaden Air Force Station, closed since 1980, is now a ghost town of 88 abandoned buildings contaminated with asbestos and lead paint. The Army Corps of Engineers, Representative Mike Honda and the new district general manager are working together to get funding from Washington to remove the buildings and to open a small visitor center.
Plans for trails and land usage are being finalized and should be released by early 2010. The goal is to open up 80 percent of the site for the public to enjoy the 3,486-foot peak towers rising above South San Jose and Los Gatos.
Mesothelioma is a deadly cancer that occurs in individuals exposed to asbestos. Please explore our Website for more detailed information on Mesothelioma, including diagnosis, treatment, clinical trials, doctors and hospitals treating the disease, and your legal options.
Mount Umunhum Cleanup
Labels: Mesothelioma, Treatments
posted by Your Attorney at 1:14 PM
The Barbara Ann Karmanos Cancer Institute, in Detroit, Michigan has achieved another first in the research and treatment of mesothelioma, according to a March 28 announcement at the Asbestos Disease Awareness Organization's annual conference. The center announced that their use of a new form of radiography allows a look at lesions caused by asbestos exposure at an earlier stage than current options.
The approach developed by Carmen Endress, M.D., FACR, Associate Professor of Radiology, Wayne State University School of Medicine, could have a significant impact by reducing the death rate from asbestos-related diseases through early detection.
In addition to early detection, doctors could realize improved success in the treatment of asbestos-related diseases through the ability to better differentiate between scarring on the lungs and other diseases, as well as understanding the associated pain with thickening of the covering of the lungs.
The Barbara Ann Karmanos Cancer Institute is one of 40 National Cancer Institute-designated comprehensive cancer centers in the United States. The Institute strives to prevent, detect and eradicate all forms of cancer.
Learn more about the Barbara Ann Karmanos Cancer Institute at www.karmanos.org. To find out more about mesothelioma research, please review our Website. You will find information including diagnosis, treatment, clinical trials, doctors and hospitals treating the disease, and your legal options.
Early Detection of Mesothelioma
Labels: Mesothelioma, Treatments
posted by Your Attorney at 11:18 AM
Friday, March 27, 2009
Students from the Dance Dynamics studio in Rancho Santa Margarita, California, performed in a fundraiser on March 7, 2009, to raise money for mesothelioma research.The money was donated to the Mesothelioma Applied Research Foundation, a non-profit organization dedicated to ending the suffering caused by mesothelioma.
The benefit was offered to provide support for one of the dancers' father diagnosed with the disease in 2006. The studio hoped to not only bring awareness of mesothelioma to the students, but to also instill a sense of community service.
The Breath of Hope Club, an organization formed by the ill man’s daughter, which raises awareness for mesothelioma research, provided snack bar staffing and front door management services. All proceeds were donated to the cause.
Visit our website to learn more about how you can support mesothelioma research. In addition, you will find information including diagnosis, treatment, clinical trials, doctors and hospitals treating the disease, and your legal options.
Mesothelioma Dance Fundraiser
Labels: Mesothelioma, Treatments
posted by Your Attorney at 4:34 PM
Personalized Medicine, or theranostics, is the integration of therapeutics and diagnostics. This type of medicine follows the concept that a patient's specific characteristics, such as height, weight, gender, and age, can be used to tailor medical care, as opposed to treating all patients the same.Theranostics has moved pharmaceuticals further into the use of genetic testing to determine the correct treatment for a given disease. In the past large companies have dominated the market, but specialized companies are now beginning to play a role.
Rosetta Genomics is one such company involved in micro RNA testing. The company reported its first revenues recently, as well as demonstrating a two-fold decrease in liver cancer tumor-mass using their therapies. Another of their diagnostic tests, miRview(TM) meso, differentiates mesothelioma from other carcinomas in the lung.
With more and more companies entering the theranostics market, in the long run a lower cost of care should be realized by eliminating unnecessary and ineffective treatment.
To learn more about continued mesothelioma medical companies look through our website. You will find information including diagnosis, treatment, clinical trials, doctors and hospitals treating the disease, and your legal options.
Personalized Medicine
Labels: Mesothelioma, Treatments
posted by Your Attorney at 4:16 PM
The Mesothelioma Applied Research Foundation (MARF) has announced the dates for its 2009 International Symposium on Malignant Mesothelioma. It will be held June 25-27 at the Omni Shoreham Hotel in Washington, D.C. Registration is available now on the MARF website.The Symposium provides information on the latest advances in research and treatment for patients and caregivers, along with educational forums on medical topics, and information on volunteer opportunities. Recognition is also given to outstanding advocates and volunteers.
In past years, patients and caregivers have found the Symposium to be an excellent place to find support among others who are suffering from mesothelioma.
Past speakers include leaders in the field of mesothelioma treatment and research such as Dr. Robert N. Taub, Dr. Pingpank, and Dr. Anne S. Tsao.
Scholarships for Symposium registration fee, transportation, and accommodations are available for patients, family members, and caregivers.
For more information, please visit the MARF website.
Labels: Mesothelioma, Treatments
posted by Your Attorney at 11:56 AM
Thursday, March 26, 2009
A 49 year-old mesothelioma patient, previously given 6 months to live, just received news that her tumor has shrunk by 73 percent.The mother of three from England participated in a clinical trial in Frankfurt, Germany, in a treatment known as chemoembolization. It introduces chemotherapy drugs directly to the tumor area through a catheter into the lung.
The patient used the compensation she received from the Ministry of Defense in England to cover the costs of the treatments. She claimed her mesothelioma was contracted by hugging her father, a dockyard worker, as a child.
The treatments, typically used in liver cancer patients, have been used on 500 patients a year. The results have had a 60% success rate, indicating that they are able to prolong the life of 60% of the patients.
To learn more about continued mesothelioma research please look through our Website. You will find information including diagnosis, treatment, clinical trials, doctors and hospitals treating the disease, and your legal options.
German Mesothelioma Clinical Trial
Labels: Mesothelioma, Treatments
posted by Your Attorney at 3:13 PM
Friday, March 20, 2009
Columbia University has announced enrollment in a Phase II clinical trial to determine the effectiveness of chemotherapy drug treatment program aimed at treating malignant pleural or peritoneal mesothelioma.
The trial will determine the effectiveness of a course of treatment combining the drugs oxaliplatin and gemcitabin in treating tumors in patinetes who have not received more than one previous course of chemotherapy.
Oxaliplatin and Gemcitabine inhibit the replication of cancer cells and previous studies have shown that there may be benefits in combing the drugs to help fight mesothelioma.
To be considered for the study, patients must be at least 18 years of age and have histologically confirmed malignant pleural or peritoneal mesothelioma which is not able to be treated surgically.
Please explore our website for more detailed information on Mesothelioma, including diagnosis, treatment, clinical trials, doctors and hospitals treating the disease, and your legal options.
Labels: Mesothelioma, Treatments
posted by L.Vaughn at 8:15 AM
Friday, March 13, 2009
Carl H. June, M.D., a professor of Pathology and Laboratory Medicine and director of Translational Research at Penn's Abramson Cancer Center, recently led a study that generated altered immune cells that shrank, and in some cases wiped out, large tumors in mice."Based on the size of the tumors and the number of cells administered, we estimate that one mesothelin-targeted T cell was able to kill about 40 tumor cells," said Dr. June.
Clinical trials are being developed to investigate this approach in patients with mesothelioma and ovarian cancer.
To learn more about this remarkable researcher, see his online bio. Also, please look through our website for more detailed information on Mesothelioma, including diagnosis, treatment, clinical trials, doctors and hospitals treating the disease, and your legal options.
Labels: Mesothelioma, Treatments
posted by Your Attorney at 10:42 AM
Thursday, March 12, 2009
In a recent study announced in February, researchers generated altered immune cells that were able to shrink -- and in some cases wipe out -- large tumors in mice.The scientific research provides a ray of hope in the fight against Mesothelioma.
"Based on the size of the tumors and the number of cells administered, we estimate that one mesothelin-targeted T cell was able to kill about 40 tumor cells," said study leader Carl H. June, M.D., Professor of Pathology and Laboratory Medicine and director of Translational Research at Penn's Abramson Cancer Center.
"This finding indicates that small doses of these cells may have potential in treating patients with large tumors," Dr. June said in a press release.
Clinical trials are being developed to investigate this approach in patients with mesothelioma and ovarian cancer.
Please explore our website for more detailed information on Mesothelioma, including diagnosis, treatment, clinical trials, doctors and hospitals treating the disease, and your legal options.
Labels: Mesothelioma, Treatments
posted by Your Attorney at 10:35 AM
Wednesday, March 11, 2009
Clinical trials are research studies that involve people. They are the final step in a long process that begins with research in a lab and animal testing. Many treatments used today are the result of past clinical trials. If you're interested in taking part in a clinical trial, this site walks you through the process.
In the meantime, we invite you to explore our website for more detailed information on Mesothelioma, including diagnosis, treatment, clinical trials, doctors and hospitals treating the disease, and your legal options.
Labels: Mesothelioma, Treatments
posted by Your Attorney at 10:31 AM
Sunday, March 8, 2009
After cancer treatment, many survivors want to find ways to prolong the days of relatively good health. Some patients worry that what they eat, the stress in their lives, or their exposure to chemicals may put them at risk. Cancer survivors find that this is a time when they take a good look at how they take care of themselves. This is an important start to living a healthy life.
Here is a booklet that you may find helpful. Also, please explore our website for more detailed information on Mesothelioma, including diagnosis, treatment, clinical trials, doctors and hospitals treating the disease, and your legal options.
Labels: Mesothelioma, Treatments
posted by Your Attorney at 10:23 AM
Thursday, March 5, 2009
Morphotek has announced the beginning of a phase II clinical trial investigating the efficacy of the monoclonal antibody MORAb-009 for the treatment of mesothelioma. The study will evaluate progression-free survival in patients with advanced pleural mesothelioma who are being receiving MORAb-009 in combination with the standard mesothelioma treatment regimen, pemetrexed + cisplatin.Continue Reading >
Labels: Mesothelioma, Treatments
posted by Your Attorney at 7:13 PM
Mesothelioma is a deadly cancer that occurs in individuals exposed to asbestos. Mesothelioma victims have inhaled asbestos fibers which then travel through the lung and become lodged in the pleura (the thin, saran wrap-type membrane lining the lungs.) Each year 2,500 to 4,000 patients in the U.S. are diagnosed with mesothelioma.
While many uses for asbestos were banned in the 1970's, the risk from exposure continues today due to mesothelioma's long latency (inactive) period of anywhere between 10 - 50 years. That is, many individuals exposed to asbestos in shipyards, construction, brake work, power plants, and other industries in the 1950's, 60's, and 70's are just now being diagnosed with mesothelioma. Today, asbestos continues to be a threat to workers exposed through their occupations and in buildings that were erected prior to the ban. Experts predict that mesothelioma diagnoses will continue to increase in the United States for at least another 10 to 20 years.
Asbestos fibers are so toxic, that industrial and trade worker's families may be exposed to mesothelioma through particles that cling to the worker's clothing, shoes, skin and hair. Asbestos was used in many products and equipment.
Please explore our website for more detailed information on Mesothelioma, including diagnosis, treatment, clinical trials, doctors and hospitals treating the disease, and your legal options.
posted by Your Attorney at 3:05 PM
News Categories
Contributing Author
Wade Rawlins is a former environmental reporter with the Raleigh News & Observer.
Editorial Board
- Mike Dayton, Editor
- Nancy Meredith, Writer
- Aaron Phelps, Writer
- Lisa Vaughn, Contributor
Resources For Living
Mesothelioma Forum
Legal Help Blog
Mesothelioma Blog
Find a Doctor Near You
Latest News
- Virginia Senate Rejects Special Shield for Asbesto...
- Resolution Proposes Asbestos Awareness Week for Ap...
- Immunotherapy Targets Cancer Cells in Mesothelioma...
- Researchers Seek Antibodies that Predict Mesotheli...
- Trades Workers in Australia at Risk of Asbestos Ex...
- Roadmap Proposed for Research on Asbestos and Susp...
- New Cancer Drug Tested in England
- EPA Investigates Asbestos Exposure in Kansas Priso...
- Defense Department Increases Funding for Mesotheli...
- Kentucky Senate Designates a Day to Reflect on Mes...
